Medycyna Paliatywna

Pełna treść

3/2026 vol. 18
Artykuł oryginalny

Social attitudes toward individuals diagnosed with cancer: a cross-sectional study

  1. Department of Rehabilitation, Faculty of Health Sciences in Katowice, Medical University of Silesia in Katowice, Poland

  2. Department of Public Health, Faculty of Public Health in Bytom, Medical University of Silesia in Katowice, Poland

  3. Department of Health Economics and Health Management, Faculty of Public Health in Bytom, Medical University of Silesia in Katowice, Poland

  4. Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Medycyna Paliatywna 2026; 18(3): 180–187

Data publikacji online: 2026/09/15
Plik artykułu
Social attitudes.pdf


Introduction

Cancer is not only a major medical challenge but also a condition associated with profound psychosocial consequences. The diagnosis of cancer often affects multiple spheres of a patient’s life, including emotional well-being, social functioning, and interpersonal relationships [1, 2]. Social attitudes toward individuals affected by cancer play a crucial role in shaping their experience of illness, influencing both psychological adjustment and quality of life. Support from family members, friends, and the wider social environment can help reduce stress, alleviate feelings of isolation, and contribute positively to treatment outcomes and recovery processes [3]. At the same time, cancer remains a disease burdened with fear, uncertainty, and persistent social stereotypes. In many societies, erroneous beliefs about cancer (such as its perceived contagiousness, inevitable fatal outcome, or association with physical and social decline) continue to exist. These misconceptions may lead to social distancing, avoidance, and stigmatisation of people living with cancer [4]. As a consequence, individuals affected by the disease may experience discrimination or subtle forms of exclusion, which can significantly undermine their psychological well-being [5, 6].

Negative social attitudes and fear of rejection may prompt people with cancer to conceal their diagnosis, limit social interactions, withdraw from professional life, or avoid discussing their health condition openly [7]. Such behaviours, driven by anticipated stigma, often exacerbate emotional distress and may hinder both psychological recovery and reintegration into everyday life after treatment [8]. Social stigma thus becomes an additional burden accompanying the medical challenges of the disease.

On the other hand, advances in oncology, improved survival rates, and the growing presence of public health campaigns have contributed to increasing awareness and knowledge about cancer. In many contemporary societies, cancer is no longer perceived solely as a terminal illness, and supportive attitudes toward patients are becoming more common [9]. Nevertheless, the degree of social acceptance remains uneven and may vary depending on the type of cancer, socio-demographic characteristics, and personal experience with the disease [10]. Identifying areas in which stigmatising attitudes persist remains an important task for both researchers and public health practitioners, as reducing social stigma is essential for improving the quality of life of people affected by cancer and promoting social inclusion [11].

The aim of this study is to assess social attitudes toward individuals diagnosed with different types of cancer, with particular attention to the role of the disease type in shaping levels of social acceptance. Additionally, the study seeks to examine how selected socio-demographic factors influence attitudes toward people with cancer.

The following research questions were formulated:

  • does the type of cancer affect the level of social acceptance of the affected person,

  • do attitudes toward people with cancer differ depending on the respondent’s gender,

  • does age influence declared levels of acceptance toward individuals with cancer,

  • is the level of education associated with attitudes toward people suffering from cancer,

  • does personal experience with cancer (one’s own or that of a close relative) influence social attitudes,

  • does place of residence (urban vs. rural) affect attitudes toward people with cancer.

Materials and methods

Study design and participants

The study was conducted on a sample of 500 adult participants aged 18–65 years. A quota random sampling procedure was applied in order to obtain a group reflecting the general population structure with regard to basic sociodemographic characteristics, while ensuring balanced representation of key variables. The sample consisted of 250 women and 250 men.

Participants were distributed across three age categories: 18–34 years (34%), 35–50 years (38%), and 51–65 years (28%). The educational structure of the sample was diversified: 42% of respondents had primary or vocational education, 28% had secondary education, and 30% had higher education. With regard to the place of residence, 46% of participants lived in large cities, while 54% resided in small towns or rural areas. An important variable considered in the study was personal experience with cancer. Slightly more than half of the respondents (52%) declared that they had either been diagnosed with cancer themselves or had a close family member affected by the disease

Research procedure

The study was conducted using a direct survey method. Participants were individually presented with a series of standardised case descriptions concerning various types of cancer. Each case was accompanied by photographs illustrating typical symptoms or visible consequences of the disease.

A total of ten cancer types were included in the study: lung cancer, breast cancer, colorectal cancer, prostate cancer, leukemia, lymphoma, melanoma, oral cancer, laryngeal cancer requiring a tracheostomy, and bone cancer potentially leading to limb amputation. The selected conditions differed with respect to visibility of symptoms and degree of physical disfigurement. Some diagnoses were associated with clearly visible bodily changes (e.g., facial deformities, surgical scars, amputations), whereas others did not involve externally observable symptoms. The order of presentation of the cases was randomised for each participant in order to control for possible order effects.

Measurement instrument

After reviewing each case description and accompanying images, participants completed the onco- logy patients social acceptance scale (OSA-7), which assesses attitudes toward individuals diagnosed with cancer [12]. The OSA-7 demonstrates satisfactory internal consistency (Cronbach’s  = 0.83), with all items showing positive correlations with the total score (r = 0.55–0.70) [12]. The questionnaire is a supplement to the present manuscript.

The oncology patients social acceptance scale is a standardised instrument consisting of seven statements referring to emotional, cognitive, and behavioural aspects of social attitudes toward people with cancer [12]. Example items include: I feel comfortable talking about cancer with a person who is ill and I believe that people with cancer deserve support and understanding from others. Responses are provided on a five-point Likert scale ranging from 1 (“strongly disagree”) to 5 (“strongly agree”).

One item (item 4: I feel that cancer can affect interpersonal relationships, and I am not sure how to react to that) is reverse-coded, as agreement with this statement reflects uncertainty and lower social acceptance. The total OSA-7 score is calculated as the sum of responses to all seven items and ranges 7–35 points, with higher scores indicating greater social acceptance.

According to the scale’s guidelines, the following interpretation was adopted [12]:

  • 7–14 points – low acceptance (high discomfort and social distance),

  • 15–21 points – moderate acceptance,

  • 22–28 points – high acceptance,

  • 29–35 points – very high acceptance.

Each participant completed the OSA-7 questionnaire separately for all ten cancer cases. In addition to the OSA-7 scale, the questionnaire included items assessing participants’ sociodemographic characteristics, such as age, gender, level of education, place of residence, and personal experience with cancer. These variables were used to examine differences and associations between demographic factors and levels of social acceptance. Additionally, an overall mean acceptance score was calculated for each respondent, reflecting their general attitude toward people with cancer.

Statistical analysis

Statistical analyses were conducted using Statistica 13 software. Descriptive statistics were calculated for all variables. To compare levels of social acceptance across different types of cancer, a repeated- measures analysis of variance (ANOVA) was performed, with cancer type treated as a within-subject factor. When significant effects were identified, post hoc comparisons were conducted using Tukey’s test. To examine the influence of sociodemographic variables on overall acceptance scores, independent samples Student t-tests were used for dichotomous variables (gender, personal experience with cancer, place of residence). One-way analysis of variance was applied for variables with more than two categories (age group and level of education). The level of statistical significance was set at  = 0.05.

Results

Overall, the respondents demonstrated relatively positive attitudes toward individuals diagnosed with cancer. The mean overall OSA-7 score, averaged across all evaluated cases, was M = 24.2 (SD ≈ 5.0), which falls within the range of high social acceptance. This indicates that, in general, participants expressed favourable and empathetic attitudes toward people affected by cancer. Nevertheless, substantial variation in acceptance levels was observed depending on the type of cancer, and (as expected) several sociodemographic variables were found to significantly influence OSA-7 scores. Detailed results are presented below.

Differences in social acceptance depending on the cancer type

A repeated-measures analysis of variance confirmed that the type of cancer significantly affected the level of social acceptance attributed to the patient (F(9, 491) = 18.37, p < 0.001). Mean OSA-7 scores for each cancer type are presented in Table 1.

The lowest levels of acceptance were observed for cancers associated with visible physical changes and bodily disfigurement. In particular, patients described as suffering from oral cancer (affecting the face) received the lowest scores (M = 20.8, SD = 6.0), followed by individuals with laryngeal cancer requiring a tracheostomy (M = 21.5). These values were significantly lower than those obtained for cancers without visible external symptoms (p < 0.001). Similarly, relatively low acceptance was reported for advanced melanoma (M = 22.3) and bone cancer involving limb amputation (M = 22.0). Although these scores still fall within the upper range of moderate acceptance, they remain clearly lower than those observed for non-disfiguring cancers. In contrast, the highest levels of social acceptance were recorded for internal malignancies that do not directly affect physical appearance. Patients with leukemia achieved a mean score of M = 27.1 (SD = 4.1), followed by lymphoma (M = 26.7, SD = 4.3) and prostate cancer (M = 26.4, SD = 4.2). These values were significantly higher than those observed for cancers involving visible bodily changes (pairwise comparisons: p < 0.01–0.001). Slight differences were also noted within the group of internal cancers. For instance, lung cancer (M = 25.0) and breast cancer (M = 24.5) received slightly lower acceptance scores compared to leukemia or lymphoma; however, their scores remained significantly higher than those assigned to cancers associated with physical disfigurement. Overall, the findings clearly indicate that cancers involving visible bodily changes or disfigurement are associated with lower levels of social acceptance, whereas conditions without external manifestations tend to evoke more positive social attitudes.

Sociodemographic differences in social acceptance

A statistically significant difference in the level of social acceptance was observed between male and female respondents. Men demonstrated a higher overall level of acceptance toward individuals with cancer (M = 25.3, SD = 4.7) compared to women (M = 23.2, SD = 5.1). This difference was statistically significant (t(498) = 4.58, p < 0.001), indicating that men declared slightly more positive and accepting attitudes toward people affected by cancer than women. Age was also found to significantly differentiate attitudes toward individuals with cancer. One-way analysis of variance revealed a significant effect of the age group on the overall OSA-7 score (F(2, 497) = 15.29, p < 0.001). Acceptance increased with respondents’ age. The highest level of acceptance was observed among the oldest participants aged 51–65 years (M = 26.7, SD = 4.4), followed by the middle-aged group (35–50 years; M = 24.8, SD = 4.9), while the lowest scores were recorded among the youngest respondents aged 18–34 years (M = 22.9, SD = 5.3). Post hoc comparisons showed that the difference between the oldest and youngest groups was statistically significant (p < 0.001), as was the difference between the middle-aged and youngest groups (p < 0.01). The difference between the middle-aged and oldest groups did not reach statistical significance (p ≈ 0.07). These findings indicate a clear tendency for social acceptance of people with cancer to increase with age. Significant differences were also observed with respect to educational level (F(2, 497) = 9.81, p < 0.001). Respondents with higher education reported the highest levels of acceptance (M = 26.3, SD = 4.6), whereas those with primary or vocational education demonstrated the lowest acceptance (M = 22.5, SD = 5.5). Participants with secondary education occupied an intermediate position (M = 24.5, SD = 4.8). Post hoc Tukey’s tests indicated that all three educational groups differed significantly from one another. In particular, individuals with higher education showed significantly greater acceptance than those with primary or vocational education (p < 0.001). Differences were also significant between respondents with secondary and primary education (p < 0.01), as well as between secondary and higher education groups (p < 0.05). These results suggest a strong positive association between educational attainment and social acceptance of people living with cancer. The distribution of results by education level is presented in Table 2.

Impact of personal experience with cancer and place of residence

As expected, personal experience with cancer proved to be a significant factor differentiating social attitudes toward individuals affected by the disease. Respondents who had themselves experienced cancer or had a close family member diagnosed with cancer reported significantly higher levels of social acceptance (M = 26.0, SD = 4.5) compared to those without such experience (M = 23.8, SD = 5.2). This difference was statistically significant (t(498) = 4.11, p < 0.001). These findings indicate that direct or indirect experience with cancer is associated with greater understanding, empathy, and acceptance toward people living with the disease. Individuals familiar with cancer through personal or family experience appear to demonstrate more supportive and less stigmatising attitudes toward others affected by oncological illness. In contrast, place of residence did not significantly differentiate respondents’ attitudes. The mean OSA-7 score among urban residents (M = 24.5, SD = 5.0) was very similar to that observed among rural residents (M = 24.0, SD = 5.2). The difference was not statistically significant (t(498) = 1.14, p = 0.254), indicating that living in a city or in a rural area does not meaningfully influence levels of social acceptance toward people with cancer.

Discussion

The present study confirms that social attitudes toward individuals diagnosed with cancer constitute a complex and multidimensional phenomenon shaped by psychological, social, and cultural factors. Although the overall level of acceptance toward people with cancer observed in the study was relatively high, a more detailed analysis revealed substantial differences depending on the cancer type, demographic characteristics, and personal experience with the disease. These findings are consistent with previous international research on cancer-related stigma and social functioning, highlighting the persistent relevance of social perceptions in shaping the lived experience of oncology patients [5, 13]. The results also emphasise that, despite increasing public awareness, cancer remains a condition that evokes ambivalent reactions and continues to be associated with specific social fears and stereotypes.

One of the most important findings of the study is the significant impact of the cancer type on levels of social acceptance. The lowest acceptance scores were observed for cancers associated with visible physical changes and bodily disfigurement, such as oral cancer, laryngeal cancer, melanoma, and bone cancer involving amputation. This pattern supports the assumption that visual and aesthetic factors play a crucial role in shaping social reactions toward people with cancer. The visibility of illness appears to intensify discomfort, uncertainty, and social distance, thereby reinforcing stigmatising attitudes [14, 15].

These results are consistent with the stigma framework described by Liu et al. [16], who demonstrated that visible signs of cancer often trigger cultural stereotypes and fears related to contamination, mortality, and physical deterioration, leading to avoidance behaviours and social withdrawal. Similarly, Huang et al. [17] reported that cancer-related stigma is strongly associated with impaired body image, reduced self-esteem, and difficulties in maintaining social relationships. The present findings further confirm that visible manifestations of illness amplify stigmatisation processes and reduce social acceptance, even in populations with generally positive attitudes toward people with cancer.

Lower acceptance of visibly affected patients may also be interpreted in the context of psychological defence mechanisms. Avoidance of contact with individuals showing clear signs of disease can be understood as an unconscious strategy to distance oneself from reminders of vulnerability, suffering, and mortality. As Lockstone suggests, cancer continues to function symbolically as a “boundary experience” that evokes existential anxiety, particularly in societies where illness and death remain partially tabooed [18]. From this perspective, increasing public openness toward cancer and normalising the presence of illness in everyday life becomes a key challenge for public health communication.

In contrast, cancers that do not involve visible bodily changes (such as leukemia, lymphoma, or prostate cancer) were associated with significantly higher levels of acceptance. This finding aligns with earlier observations by Crowder et al. [19], who noted that social acceptance among cancer survivors is strongly mediated by psychosocial variables, including perceived normality and physical appearance. When the disease does not visibly disrupt social roles or physical integrity, individuals appear more likely to be perceived as “healthy enough” to participate fully in social life, thus encountering fewer barriers to acceptance.

The study also demonstrated significant effects of gender, age, and educational level on social attitudes toward people with cancer. Men reported higher levels of acceptance than women, a result that may appear counterintuitive given the commonly reported higher empathic sensitivity among women. However, this difference may reflect gender- related norms of emotional expression and perceived vulnerability. Women may express greater concern, anxiety, or caution in relation to illness, which could translate into more ambivalent or restrained attitudes when assessed using a standardised acceptance scale. Alternatively, men’s higher scores may reflect more generalised or less emotionally nuanced responses.

Age emerged as a particularly strong predictor of social acceptance. Older respondents displayed significantly higher levels of acceptance than younger participants, which is consistent with previous findings indicating that life experience, exposure to illness, and greater emotional maturity contribute to more tolerant and empathetic attitudes [20]. Older individuals are more likely to have encountered serious illness personally or within their social networks, which may foster understanding and reduce fear-based reactions. Additionally, aging is often associated with a shift in value systems toward greater compassion and social responsibility.

Education level also played a significant role in shaping attitudes toward cancer patients. Participants with higher education demonstrated the most positive attitudes, whereas those with lower educational attainment showed the lowest levels of acceptance. This pattern supports the findings of Tozlu et al. [21], who emphasised the importance of health literacy in shaping attitudes toward disease prevention, treatment, and patient support. Higher education is typically associated with better access to medical knowledge, lower susceptibility to myths and misinformation, and greater awareness of psychosocial aspects of illness. Consequently, individuals with higher education may be less prone to stigmatising beliefs and more inclined to display supportive behaviours.

Importantly, personal experience with cancer, either direct or through a close family member, was strongly associated with higher acceptance of people affected by the disease. This finding underscores the central role of experiential knowledge in shaping social attitudes. Direct exposure to illness appears to reduce fear, increase empathy, and promote understanding of the challenges faced by patients. Similar conclusions were drawn by Glajchen et al. [22], who observed that caregiving and close contact with cancer patients enhance emotional competence and reduce stigmatising perceptions. Likewise, Lazard et al. [23] demonstrated that peer support and shared illness narratives contribute to greater empathy and normalisation of cancer-related experience.

The lack of significant differences related to the place of residence suggests that social attitudes toward cancer may be becoming increasingly homogenised across urban and rural settings. This trend likely reflects broader access to health information, media campaigns, and public discourse on cancer prevention and survivorship. Contemporary educational initiatives and media coverage may be reducing traditional rural-urban disparities in health-related knowledge and attitudes, contributing to a more uniform social perception of cancer across populations.

The present findings are also consistent with broader research on the psychosocial consequences of cancer-related stigma. Studies by Pan et al. [20] have shown that stigma is strongly associated with increased anxiety, depressive symptoms, and reduced quality of life among cancer patients. Similarly, Polański et al. [24] demonstrated that social isolation and perceived rejection significantly impair psychological adjustment among individuals with lung cancer. The current results, showing lower acceptance of patients with visible symptoms, further highlight the social mechanisms that may exacerbate psychological distress and hinder reintegration into everyday life.

From a practical perspective, these findings under- score the importance of targeted educational and psychosocial interventions aimed at reducing stigma and promoting social inclusion of cancer patients. As emphasised by Huang et al. [17, 25], behavioural and psychoeducational interventions can effectively reduce stigma and improve emotional well-being among both patients and the general population. Equally important are community-based initiatives that promote open dialogue about cancer and challenge harmful stereotypes. As argued by Lockstone [18] and Kerrison et al. [26], fostering a “culture of acceptance” requires coordinated efforts involving healthcare professionals, educators, media, and policymakers.

Despite its strengths, including a large and demographically diverse sample, the present study has several limitations. First, the use of self-report measures introduces the possibility of social desirability bias, as respondents may overstate socially acceptable attitudes. Second, the study was conducted within a single national context, limiting the generalisability of the findings to other cultural settings where beliefs about illness may differ. Third, the study relied on hypothetical case descriptions rather than real-life interactions, which may not fully capture emotional and behavioural responses in naturalistic contexts. Finally, the study did not directly assess participants’ level of cancer-related knowledge, which may serve as an important moderating variable in future research.

Future studies should therefore incorporate objective measures of health literacy, longitudinal designs, and experimental interventions aimed at reducing stigma. Investigating the effectiveness of educational programs and contact-based interventions could provide valuable insights into how social acceptance of people with cancer can be strengthened in both clinical and community settings.

Conclusions

The findings of the present study confirm that social attitudes toward individuals diagnosed with cancer are significantly shaped by both medical and sociodemographic factors. First, the type of cancer plays a crucial role in determining the level of social acceptance. The acceptance of patients suffering from cancers associated with permanent bodily damage or visible physical changes is lower compared to acceptance of those whose illness does not manifest externally. This highlights the continuing importance of appearance-related stigma in shaping social responses to disease.

Second, although the overall level of acceptance toward people with cancer in the studied population was relatively high (indicating a generally empathetic social climate) clear differences emerged depending on selected sociodemographic characteristics. These findings suggest that positive attitudes toward cancer patients are not evenly distributed across the society and remain influenced by individual background factors.

Gender, age, and educational level were found to significantly differentiate social attitudes. Men demonstrated slightly higher levels of acceptance than women, while older respondents expressed more positive attitudes than younger individuals. Higher educational attainment was associated with greater acceptance, likely reflecting higher health literacy and reduced susceptibility to stereotypes. Moreover, personal experience with cancer (either through one’s own illness or that of a close relative) was a strong predictor of increased empathy and social acceptance, emphasising the role of experiential knowledge in reducing stigma.

In contrast, place of residence did not significantly influence attitudes toward people with cancer. This suggests a growing homogenisation of social perceptions, possibly resulting from widespread access to information, media coverage, and public health campaigns that transcend urban-rural divides.

Taken together, the results underline the need for continued educational and awareness-raising efforts aimed at reducing cancer-related stigma, particularly toward patients whose illness leads to visible bodily changes. Interventions should focus on increasing public understanding of cancer, challenging persistent stereotypes, and promoting positive representations of people living with the disease. Encouraging direct or indirect contact with cancer survivors may further enhance empathy and acceptance, as personal experience appears to play a key role in shaping attitudes.

Ultimately, reducing unfounded fears and promoting supportive social attitudes can contribute to improving the quality of life of people affected by cancer, facilitating their social integration, and fostering a more inclusive and compassionate society.

Disclosures

1. Institutional review board statement: This study was approved by the Ethics Committee of the Medical University of Silesia in Katowice (approval decision no. PCN/CBN/0052/KB/302/22/23, dated: 03.03.2023).

2. Assistance with the article: None.

3. Financial support and sponsorship: None.

4. Conflicts of interest: None.

References


  1. Zeng Z, Holtmaat K, Jia X, Burchell GL, Koole SL, de Leeuw IMV. Interpersonal emotion regulation and mental health among cancer survivors: A systematic review. Int J Clin Health Psychol 2025; 25: 100592.
  2. Peng M, Zhang YP, Wu Y, Li R. Analysis of the influential factors of the emotional health of patients with cancer based on the structural equation model: the role of social media and emotional support. Support Care Cancer 2023; 31: 417.
  3. Grabinski VF, Brawley OW. Disparities in breast cancer. Obstet Gynecol Clin North Am 2022; 49: 149-165.
  4. Zhang Z, Leong Bin Abdullah MFI, Shari NI, Lu P. Acceptance and commitment therapy <i>versus</i> mindfulness-based stress reduction for newly diagnosed head and neck cancer patients: a randomized controlled trial assessing efficacy for positive psychology, depression, anxiety, and quality of life. PLoS One 2022; 17: e0267887.
  5. Ernst J, Köditz AK, Goerling U, Zimmermann T, Hornemann B, Springer F, et al. Perceived stigmatization in cancer patients during the first year after diagnosis: the role of socioeconomic status. J Cancer Surviv 2025.
  6. Yigitbas C, Bulut A. Exploring psychological help-seeking behaviors and stigma perception among cancer patients: a study on their impact on psychosocial adjustment. Support Care Cancer 2024; 32: 694.
  7. Yao Q, Li G, Dong Z, Liu K, Dong X. Stigma and social withdrawal among colorectal cancer survivors with permanent stomas: the mediating role of social motivation in psychosocial adaptation. Front Psychiatry 2025; 16: 1600287.
  8. Villalona S, Sanchez J, Mangkalard P, Best AL. Understanding disclosure decisions and communication about HPV related cancer: a qualitative exploration of stigma and social support. Healthcare 2025; 13: 966.
  9. Aziz-Bose R, Zheng DJ, Umaretiya PJ, Ilcisin L, Stevenson K, Koch V, et al. Feasibility of oncology clinical trial-embedded evaluation of social determinants of health. Pediatr Blood Cancer 2022; 69: e29933.
  10. Rutenkröger M, Agrali S, Scholl I. Influence of label and academic field on cancer stigma and subjective illness theories among medicine and psychology students: a cross-sectional online study. Sci Rep 2025; 15: 2530.
  11. Li G, He X, Qin R, Yao Q, Dong X, Li P. Linking stigma to social isolation among colorectal cancer survivors with permanent stomas: the chain mediating roles of stoma acceptance and valuable actions. J Cancer Surviv 2025; 19: 2037-2046.
  12. Grajek M, Jurys T. OSA-7. 2026.
  13. Heley K, Vedham V, Vanderpool RC. The global landscape of cancer stigma research and practice: perspectives, measures, interventions, and actions for change. J Natl Cancer Inst Monogr 2024; 63: 1-3.
  14. Thompson AR, Sewards I, Baker SR. Cancer and changes in facial appearance: a meta-ethnography of qualitative studies. Br J Health Psychol 2020; 25: 129-151.
  15. Arıkan F, Kartöz F, Karakuş Z, Altınışık M, Özer Z, Şahin AFK. Body image and social appearance anxiety in patients with cancer undergoing radiotherapy: a cross-sectional study. BMC Psychol 2024; 12: 363.
  16. Liu X, Zhong J, Ren J, Zhang JE. The formation of stigma and its social consequences on Chinese people living with lung cancer: a qualitative study. Oncol Nurs Forum 2023; 50: 589-598.
  17. Huang Z, Yu T, Wu S, Hu A. Correlates of stigma for patients with cancer: a systematic review and meta-analysis. Support Care Cancer 2021; 29: 1195-1203.
  18. Lockstone A. Cancel the cancer culture! Br Dent J 2025; 238: 378-381.
  19. Crowder SL, Foster RH, Buro AW, Dillon R, Godder K, Stern M. Mediators of social acceptance among emerging adult survivors of childhood cancer. J Adolesc Young Adult Oncol 2023; 12: 644-652.
  20. Pan S, Wang L, Zheng L, Luo J, Mao J, Qiao W, et al. Effects of stigma, anxiety and depression, and uncertainty in illness on quality of life in patients with prostate cancer: a cross-sectional analysis. BMC Psychol 2023; 11: 129.
  21. Tozlu M, Okan F. Effect of health literacy on attitudes toward cancer screening among individuals aged 30–70. Public Health Nurs 2025; 42: 1585-1594.
  22. Glajchen M, Goehring A, Johns H, Portenoy RK. Family meetings in palliative care: benefits and barriers. Curr Treat Options Oncol 2022; 23: 658-667.
  23. Lazard AJ, Collins MKR, Hedrick A, Horrell LN, Varma T, Love B, et al. Initiation and changes in use of social media for peer support among young adult cancer patients and survivors. Psychooncology 2021; 30: 1859-1865.
  24. Polański J, Misiąg W, Chabowski M. Impact of loneliness on functioning in lung cancer patients. Int J Environ Res Public Health 2022; 19: 15793.
  25. Huang R, Ge H, Nie G, Li A, Liu L, Cheng L, et al. Effect of behavioral activation on stigma and quality of life in patients with advanced esophageal and gastric cancer: a randomized controlled trial. Psychooncology 2024; 33: e70021.
  26. Kerrison RS, Robinson A, Skrobanski H, Kayal G, Kaushal A, Ide-Walters C, et al. Demographic and psychological predictors of community pharmacists’ cancer-related conversations with patients: a cross-sectional analysis and survey study. BMC Health Serv Res 2022; 22: 268.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Udostępnij
without publication fees
without publication fees